(+)-catechin multiple interactions EXP 6480464 [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of WNT4 mRNA CTD PMID:24763279 (R)-adrenaline decreases expression ISO RGD:733868 6480464 Epinephrine results in decreased expression of WNT4 mRNA, Epinephrine results in decreased expression of WNT4 protein CTD PMID:31520687 (S)-nicotine multiple interactions ISO RGD:733868 6480464 Carbon Tetrachloride promotes the reaction [Nicotine results in increased expression of WNT4 mRNA] more ... CTD PMID:33640489 , PMID:35411647 (S)-nicotine increases expression ISO RGD:733868 6480464 Nicotine results in increased expression of WNT4 mRNA, Nicotine results in increased expression of WNT4 protein CTD PMID:33640489 , PMID:35411647 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane increases expression ISO RGD:733868 6480464 2 more ... CTD PMID:20826375 1,3-dinitrobenzene increases expression ISO RGD:621348 6480464 3-dinitrobenzene results in increased expression of WNT4 mRNA CTD PMID:24140754 1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine increases expression ISO RGD:621348 6480464 chlorcyclizine results in increased expression of WNT4 mRNA CTD PMID:21058326 1-naphthyl isothiocyanate increases expression ISO RGD:621348 6480464 1-Naphthylisothiocyanate results in increased expression of WNT4 mRNA CTD PMID:30723492 17alpha-ethynylestradiol affects expression ISO RGD:733868 6480464 Ethinyl Estradiol affects the expression of WNT4 mRNA CTD PMID:17555576 17alpha-ethynylestradiol affects expression ISO RGD:621348 6480464 Ethinyl Estradiol affects the expression of WNT4 mRNA CTD PMID:16551644 , PMID:17351261 17alpha-ethynylestradiol increases expression ISO RGD:733868 6480464 Ethinyl Estradiol results in increased expression of WNT4 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:733868 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of WNT4 mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO RGD:733868 6480464 Estradiol results in increased expression of WNT4 mRNA CTD PMID:19164167 more ... 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of WNT4 mRNA CTD PMID:31646340 17beta-estradiol increases expression ISO RGD:621348 6480464 Estradiol results in increased expression of WNT4 mRNA CTD PMID:31119341 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of WNT4 mRNA more ... CTD PMID:23275455 , PMID:30165855 17beta-estradiol affects expression ISO RGD:733868 6480464 Estradiol affects the expression of WNT4 mRNA CTD PMID:15598610 17beta-hydroxy-5alpha-androstan-3-one multiple interactions ISO RGD:733868 6480464 Dihydrotestosterone inhibits the reaction [Androgens deficiency results in decreased expression of WNT4 mRNA] CTD PMID:29367455 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:733868 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of WNT4 mRNA, Tetrachlorodibenzodioxin affects the reaction [AHR protein binds to WNT4 promoter] CTD PMID:17942748 , PMID:19654925 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:621348 6480464 Tetrachlorodibenzodioxin results in increased expression of WNT4 mRNA CTD PMID:21215274 , PMID:22808131 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:621348 6480464 Tetrachlorodibenzodioxin affects the expression of WNT4 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:733868 6480464 Tetrachlorodibenzodioxin results in decreased expression of WNT4 mRNA CTD PMID:19770486 , PMID:25270620 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:733868 6480464 Tetrachlorodibenzodioxin results in increased expression of WNT4 mRNA CTD PMID:17035482 , PMID:17942748 2,3,7,8-Tetrachlorodibenzofuran decreases expression ISO RGD:621348 6480464 2 more ... CTD PMID:21724226 2,4-dinitrotoluene affects expression ISO RGD:621348 6480464 2, 4-dinitrotoluene affects the expression of WNT4 mRNA CTD PMID:21346803 2-nitrotoluene increases expression ISO RGD:621348 6480464 2-nitrotoluene results in increased expression of WNT4 mRNA CTD PMID:16460773 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:621348 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of WNT4 mRNA CTD PMID:30071829 3-chloropropane-1,2-diol increases expression ISO RGD:733868 6480464 alpha-Chlorohydrin results in increased expression of WNT4 mRNA CTD PMID:33187795 4,4'-sulfonyldiphenol multiple interactions ISO RGD:621348 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of WNT4 mRNA CTD PMID:36041667 4-hydroxyphenyl retinamide increases expression ISO RGD:733868 6480464 Fenretinide results in increased expression of WNT4 mRNA CTD PMID:28973697 6-propyl-2-thiouracil decreases expression ISO RGD:621348 6480464 Propylthiouracil results in decreased expression of WNT4 mRNA CTD PMID:24780913 8-Br-cAMP decreases expression EXP 6480464 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of WNT4 mRNA CTD PMID:22079614 8-Br-cAMP multiple interactions EXP 6480464 [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of WNT4 mRNA, NR3C1 protein promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of WNT4 mRNA] CTD PMID:23275455 acetamide increases expression ISO RGD:621348 6480464 acetamide results in increased expression of WNT4 mRNA CTD PMID:31881176 acrylamide increases expression ISO RGD:621348 6480464 Acrylamide results in increased expression of WNT4 mRNA CTD PMID:28959563 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of WNT4 mRNA CTD PMID:32763439 afimoxifene increases expression EXP 6480464 afimoxifene results in increased expression of WNT4 mRNA CTD PMID:16849584 aflatoxin B1 decreases expression ISO RGD:733868 6480464 Aflatoxin B1 results in decreased expression of WNT4 mRNA CTD PMID:19770486 aflatoxin B1 increases expression ISO RGD:621348 6480464 Aflatoxin B1 results in increased expression of WNT4 mRNA CTD PMID:23630614 , PMID:25378103 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of WNT4 mRNA CTD PMID:22100608 aldehydo-D-glucose multiple interactions ISO RGD:621348 6480464 Simvastatin inhibits the reaction [Glucose results in decreased expression of WNT4 mRNA] CTD PMID:18004065 aldehydo-D-glucose decreases expression ISO RGD:621348 6480464 Glucose results in decreased expression of WNT4 mRNA CTD PMID:18004065 all-trans-retinoic acid increases expression ISO RGD:621348 6480464 Tretinoin results in increased expression of WNT4 mRNA CTD PMID:30329139 , PMID:30476341 all-trans-retinoic acid multiple interactions ISO RGD:621348 6480464 mono-(2-ethylhexyl)phthalate promotes the reaction [Tretinoin results in increased expression of WNT4 mRNA] CTD PMID:30476341 allethrin multiple interactions ISO RGD:621348 6480464 [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in increased expression of WNT4 mRNA, [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of WNT4 mRNA CTD PMID:33051911 , PMID:33396045 ammonium chloride affects expression ISO RGD:621348 6480464 Ammonium Chloride affects the expression of WNT4 mRNA CTD PMID:16483693 aristolochic acid A increases expression EXP 6480464 aristolochic acid I results in increased expression of WNT4 mRNA CTD PMID:33212167 Aroclor 1254 decreases expression ISO RGD:733868 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of WNT4 mRNA CTD PMID:25270620 arsane multiple interactions EXP 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of WNT4 mRNA CTD PMID:32525701 arsenic atom multiple interactions EXP 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of WNT4 mRNA CTD PMID:32525701 arsenite(3-) decreases expression EXP 6480464 arsenite results in decreased expression of WNT4 mRNA CTD PMID:31646340 belinostat increases expression EXP 6480464 belinostat results in increased expression of WNT4 mRNA CTD PMID:23671600 , PMID:26272509 belinostat multiple interactions EXP 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT4 mRNA CTD PMID:27188386 benzo[a]pyrene multiple interactions ISO RGD:733868 6480464 Benzo(a)pyrene promotes the reaction [AHR protein binds to WNT4 promoter] CTD PMID:19654925 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of WNT4 mRNA CTD PMID:32234424 benzo[a]pyrene decreases methylation EXP 6480464 Benzo(a)pyrene results in decreased methylation of WNT4 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:733868 6480464 Benzo(a)pyrene results in decreased expression of WNT4 mRNA CTD PMID:19770486 more ... Benzo[k]fluoranthene decreases expression ISO RGD:733868 6480464 benzo(k)fluoranthene results in decreased expression of WNT4 mRNA CTD PMID:26377693 beryllium sulfate increases expression EXP 6480464 beryllium sulfate results in increased expression of WNT4 mRNA CTD PMID:16314022 bis(2-ethylhexyl) phthalate increases expression ISO RGD:733868 6480464 Diethylhexyl Phthalate results in increased expression of WNT4 mRNA, Diethylhexyl Phthalate results in increased expression of WNT4 protein CTD PMID:26219507 , PMID:27495896 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:733868 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of WNT4 mRNA] CTD PMID:33316053 bisphenol A multiple interactions ISO RGD:733868 6480464 bisphenol A promotes the reaction [Progesterone results in increased expression of WNT4 mRNA] CTD PMID:21903720 bisphenol A multiple interactions ISO RGD:621348 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of WNT4 mRNA CTD PMID:36041667 bisphenol A decreases expression ISO RGD:621348 6480464 bisphenol A results in decreased expression of WNT4 mRNA CTD PMID:30816183 more ... bisphenol A increases expression ISO RGD:621348 6480464 bisphenol A results in increased expression of WNT4 mRNA, bisphenol A results in increased expression of WNT4 protein CTD PMID:24552547 , PMID:25181051 bisphenol A increases expression ISO RGD:733868 6480464 bisphenol A results in increased expression of WNT4 mRNA CTD PMID:20826375 more ... bisphenol F affects expression ISO RGD:733868 6480464 bisphenol F affects the expression of WNT4 mRNA CTD PMID:30951980 bisphenol F multiple interactions ISO RGD:621348 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of WNT4 mRNA CTD PMID:36041667 bromobenzene increases expression ISO RGD:621348 6480464 bromobenzene results in increased expression of WNT4 mRNA CTD PMID:32479839 bromochloroacetic acid increases expression ISO RGD:621348 6480464 bromochloroacetic acid results in increased expression of WNT4 mRNA CTD PMID:16460773 Butylbenzyl phthalate multiple interactions ISO RGD:733868 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of WNT4 mRNA] CTD PMID:33316053 cadmium atom decreases expression EXP 6480464 Cadmium results in decreased expression of WNT4 mRNA CTD PMID:31646340 cadmium sulfate multiple interactions EXP 6480464 [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in decreased expression of WNT4 mRNA CTD PMID:18654764 caffeine affects expression ISO RGD:621348 6480464 Caffeine affects the expression of WNT4 mRNA CTD PMID:20864626 calciol increases expression ISO RGD:733868 6480464 Cholecalciferol results in increased expression of WNT4 mRNA, Cholecalciferol results in increased expression of WNT4 protein CTD PMID:17170073 chlordecone increases expression ISO RGD:733868 6480464 Chlordecone results in increased expression of WNT4 mRNA CTD PMID:33711761 chlorpyrifos affects expression ISO RGD:621348 6480464 Chlorpyrifos affects the expression of WNT4 mRNA CTD PMID:26775027 choline multiple interactions ISO RGD:733868 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of WNT4 mRNA CTD PMID:20938992 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of WNT4 mRNA CTD PMID:23956100 , PMID:27392435 cisplatin multiple interactions EXP 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of WNT4 mRNA CTD PMID:27392435 clofibrate decreases expression ISO RGD:733868 6480464 Clofibrate results in decreased expression of WNT4 mRNA CTD PMID:25270620 cobalt dichloride multiple interactions EXP 6480464 [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in decreased expression of WNT4 mRNA CTD PMID:18654764 copper(II) sulfate increases expression EXP 6480464 Copper Sulfate results in increased expression of WNT4 mRNA CTD PMID:19549813 cyclosporin A increases expression ISO RGD:733868 6480464 Cyclosporine results in increased expression of WNT4 mRNA CTD PMID:19770486 cyhalothrin multiple interactions ISO RGD:621348 6480464 [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in increased expression of WNT4 mRNA, [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of WNT4 mRNA CTD PMID:33051911 , PMID:33396045 cypermethrin multiple interactions ISO RGD:621348 6480464 [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in increased expression of WNT4 mRNA, [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of WNT4 mRNA CTD PMID:33051911 , PMID:33396045 D-glucose decreases expression ISO RGD:621348 6480464 Glucose results in decreased expression of WNT4 mRNA CTD PMID:18004065 D-glucose multiple interactions ISO RGD:621348 6480464 Simvastatin inhibits the reaction [Glucose results in decreased expression of WNT4 mRNA] CTD PMID:18004065 dexamethasone decreases expression ISO RGD:621348 6480464 Dexamethasone results in decreased expression of WNT4 mRNA CTD PMID:20032058 dexamethasone multiple interactions ISO RGD:621348 6480464 Testosterone inhibits the reaction [Dexamethasone results in decreased expression of WNT4 mRNA] CTD PMID:20032058 diazinon affects expression ISO RGD:621348 6480464 Diazinon affects the expression of WNT4 mRNA CTD PMID:19130878 dibutyl phthalate decreases expression ISO RGD:621348 6480464 Dibutyl Phthalate results in decreased expression of WNT4 mRNA CTD PMID:21266533 dibutyl phthalate multiple interactions ISO RGD:733868 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of WNT4 mRNA] CTD PMID:33316053 dieldrin affects expression ISO RGD:621348 6480464 Dieldrin affects the expression of WNT4 mRNA CTD PMID:19130878 diethyl phthalate multiple interactions ISO RGD:733868 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of WNT4 mRNA] CTD PMID:33316053 diethylstilbestrol affects expression ISO RGD:733868 6480464 Diethylstilbestrol affects the expression of WNT4 mRNA CTD PMID:15070830 diethylstilbestrol multiple interactions ISO RGD:733868 6480464 fulvestrant inhibits the reaction [Diethylstilbestrol results in increased expression of WNT4 mRNA] CTD PMID:22445810 diethylstilbestrol increases expression ISO RGD:733868 6480464 Diethylstilbestrol results in increased expression of WNT4 mRNA, Diethylstilbestrol results in increased expression of WNT4 protein CTD PMID:22445810 diisobutyl phthalate multiple interactions ISO RGD:733868 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of WNT4 mRNA] CTD PMID:33316053 diisononyl phthalate multiple interactions ISO RGD:733868 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] inhibits the reaction [CGA protein results in increased expression of WNT4 mRNA] CTD PMID:33316053 diuron decreases expression ISO RGD:621348 6480464 Diuron results in decreased expression of WNT4 mRNA CTD PMID:21551480 dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of WNT4 mRNA CTD PMID:23956100 entinostat increases expression EXP 6480464 entinostat results in increased expression of WNT4 mRNA CTD PMID:26272509 entinostat multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT4 mRNA CTD PMID:27188386 ethanol affects expression ISO RGD:733868 6480464 Ethanol affects the expression of WNT4 mRNA CTD PMID:30319688 fenvalerate multiple interactions ISO RGD:621348 6480464 [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in increased expression of WNT4 mRNA, [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of WNT4 mRNA CTD PMID:33051911 , PMID:33396045 folic acid multiple interactions ISO RGD:733868 6480464 [Folic Acid co-treated with sodium arsenite] results in decreased methylation of WNT4 mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of WNT4 mRNA CTD PMID:20938992 , PMID:22959928 formaldehyde decreases expression EXP 6480464 Formaldehyde results in decreased expression of WNT4 mRNA CTD PMID:27664576 fulvestrant multiple interactions ISO RGD:733868 6480464 fulvestrant inhibits the reaction [Diethylstilbestrol results in increased expression of WNT4 mRNA] CTD PMID:22445810 fulvestrant decreases expression EXP 6480464 Fulvestrant results in decreased expression of WNT4 mRNA CTD PMID:31646340 genistein increases expression ISO RGD:733868 6480464 Genistein results in increased expression of WNT4 mRNA CTD PMID:24365114 genistein decreases expression ISO RGD:733868 6480464 Genistein results in decreased expression of WNT4 mRNA, Genistein results in decreased expression of WNT4 protein CTD PMID:32186404 gentamycin decreases expression ISO RGD:621348 6480464 Gentamicins results in decreased expression of WNT4 mRNA CTD PMID:33387578 glucose decreases expression ISO RGD:621348 6480464 Glucose results in decreased expression of WNT4 mRNA CTD PMID:18004065 glucose multiple interactions ISO RGD:621348 6480464 Simvastatin inhibits the reaction [Glucose results in decreased expression of WNT4 mRNA] CTD PMID:18004065 hydroquinone decreases expression EXP 6480464 hydroquinone results in decreased expression of WNT4 mRNA CTD PMID:31256213 indole-3-methanol affects expression ISO RGD:621348 6480464 indole-3-carbinol affects the expression of WNT4 mRNA CTD PMID:21396975 indometacin decreases expression ISO RGD:621348 6480464 Indomethacin results in decreased expression of WNT4 mRNA CTD PMID:25972201 L-methionine multiple interactions ISO RGD:733868 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of WNT4 mRNA CTD PMID:20938992 lead nitrate multiple interactions ISO RGD:733868 6480464 lead nitrate affects the reaction [WNT4 affects the expression of MT1 mRNA], lead nitrate affects the reaction [WNT4 affects the expression of MT2 mRNA] CTD PMID:11891201 lead(0) affects expression EXP 6480464 Lead affects the expression of WNT4 mRNA CTD PMID:28903495 lead(2+) affects expression EXP 6480464 Lead affects the expression of WNT4 mRNA CTD PMID:28903495 lead(II) chloride multiple interactions EXP 6480464 [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in decreased expression of WNT4 mRNA CTD PMID:18654764 Licochalcone B increases expression EXP 6480464 licochalcone B results in increased expression of WNT4 mRNA CTD PMID:33647349 lipopolysaccharide multiple interactions EXP 6480464 S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of WNT4 mRNA] CTD PMID:35811015 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of WNT4 mRNA CTD PMID:35811015 mono(2-ethylhexyl) phthalate multiple interactions ISO RGD:621348 6480464 mono-(2-ethylhexyl)phthalate promotes the reaction [Tretinoin results in increased expression of WNT4 mRNA] CTD PMID:30476341 mono(2-ethylhexyl) phthalate increases expression ISO RGD:621348 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of WNT4 mRNA CTD PMID:30476341 N-nitrosodiethylamine multiple interactions ISO RGD:733868 6480464 [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of WNT4 gene CTD PMID:23968726 N-Nitrosopyrrolidine increases expression EXP 6480464 N-Nitrosopyrrolidine results in increased expression of WNT4 mRNA CTD PMID:32234424 N-Vinyl-2-pyrrolidone multiple interactions ISO RGD:621348 6480464 [N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which results in increased expression of WNT4 mRNA CTD PMID:22037397 nickel atom affects expression ISO RGD:621348 6480464 Nickel affects the expression of WNT4 mRNA CTD PMID:19130878 nickel atom multiple interactions ISO RGD:621348 6480464 [nickel sulfate results in increased abundance of Nickel] which results in decreased expression of WNT4 mRNA CTD PMID:31734292 nickel atom decreases expression EXP 6480464 Nickel results in decreased expression of WNT4 mRNA CTD PMID:24768652 , PMID:25583101 nickel sulfate multiple interactions ISO RGD:621348 6480464 [nickel sulfate results in increased abundance of Nickel] which results in decreased expression of WNT4 mRNA CTD PMID:31734292 nicotine multiple interactions ISO RGD:733868 6480464 Carbon Tetrachloride promotes the reaction [Nicotine results in increased expression of WNT4 mRNA] more ... CTD PMID:33640489 , PMID:35411647 nicotine increases expression ISO RGD:733868 6480464 Nicotine results in increased expression of WNT4 mRNA, Nicotine results in increased expression of WNT4 protein CTD PMID:33640489 , PMID:35411647 O-methyleugenol increases expression EXP 6480464 methyleugenol results in increased expression of WNT4 mRNA CTD PMID:32234424 paclitaxel increases expression EXP 6480464 Paclitaxel results in increased expression of WNT4 mRNA CTD PMID:23956100 panobinostat multiple interactions EXP 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT4 mRNA CTD PMID:27188386 panobinostat increases expression EXP 6480464 panobinostat results in increased expression of WNT4 mRNA CTD PMID:26272509 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of WNT4 mRNA CTD PMID:29067470 paracetamol increases expression ISO RGD:621348 6480464 Acetaminophen results in increased expression of WNT4 mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:621348 6480464 Acetaminophen results in decreased expression of WNT4 mRNA CTD PMID:30723492 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of WNT4 mRNA CTD PMID:35548680 phenobarbital increases expression ISO RGD:621348 6480464 Phenobarbital results in increased expression of WNT4 mRNA CTD PMID:22037397 phenylmercury acetate multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT4 mRNA CTD PMID:27188386 picene decreases expression EXP 6480464 picene results in decreased expression of WNT4 mRNA CTD PMID:32251684 piperonyl butoxide multiple interactions ISO RGD:733868 6480464 [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of WNT4 gene CTD PMID:23968726 pirinixic acid decreases expression ISO RGD:733868 6480464 pirinixic acid results in decreased expression of WNT4 mRNA CTD PMID:25270620 progesterone affects expression ISO RGD:733868 6480464 Progesterone affects the expression of WNT4 mRNA CTD PMID:17251523 progesterone affects abundance ISO RGD:733868 6480464 WNT4 protein affects the abundance of Progesterone CTD PMID:20371632 progesterone multiple interactions EXP 6480464 [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of WNT4 mRNA, NR3C1 protein promotes the reaction [[Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of WNT4 mRNA] CTD PMID:23275455 progesterone multiple interactions ISO RGD:621348 6480464 [Progesterone co-treated with Estrogens] results in increased expression of WNT4 mRNA CTD PMID:21258428 progesterone decreases expression ISO RGD:733868 6480464 Progesterone results in decreased expression of WNT4 mRNA CTD PMID:22238285 progesterone increases expression ISO RGD:733868 6480464 Progesterone results in increased expression of WNT4 mRNA CTD PMID:21903720 progesterone multiple interactions ISO RGD:733868 6480464 bisphenol A promotes the reaction [Progesterone results in increased expression of WNT4 mRNA] CTD PMID:21903720 rotenone increases expression ISO RGD:733868 6480464 Rotenone results in increased expression of WNT4 mRNA CTD PMID:32937126 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions EXP 6480464 S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of WNT4 mRNA] CTD PMID:35811015 SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 simvastatin multiple interactions ISO RGD:621348 6480464 Simvastatin inhibits the reaction [Glucose results in decreased expression of WNT4 mRNA] CTD PMID:18004065 simvastatin increases expression ISO RGD:621348 6480464 Simvastatin results in increased expression of WNT4 protein CTD PMID:18004065 sodium arsenate multiple interactions EXP 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of WNT4 mRNA CTD PMID:32525701 sodium arsenite multiple interactions ISO RGD:733868 6480464 [Folic Acid co-treated with sodium arsenite] results in decreased methylation of WNT4 mRNA CTD PMID:22959928 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of WNT4 mRNA CTD PMID:34032870 sodium arsenite affects expression ISO RGD:621348 6480464 sodium arsenite affects the expression of WNT4 mRNA CTD PMID:23137061 Soman decreases expression ISO RGD:621348 6480464 Soman results in decreased expression of WNT4 mRNA CTD PMID:19281266 sotorasib multiple interactions EXP 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of WNT4 mRNA CTD PMID:36139627 tamoxifen affects expression ISO RGD:733868 6480464 Tamoxifen affects the expression of WNT4 mRNA CTD PMID:17555576 tert-butyl hydroperoxide increases expression ISO RGD:733868 6480464 tert-Butylhydroperoxide results in increased expression of WNT4 mRNA CTD PMID:15003993 testosterone decreases expression ISO RGD:733868 6480464 Testosterone results in decreased expression of WNT4 mRNA CTD PMID:20403060 testosterone increases expression EXP 6480464 Testosterone results in increased expression of WNT4 mRNA CTD PMID:33359661 testosterone multiple interactions ISO RGD:621348 6480464 Testosterone inhibits the reaction [Dexamethasone results in decreased expression of WNT4 mRNA] CTD PMID:20032058 tetrachloromethane increases expression ISO RGD:621348 6480464 Carbon Tetrachloride results in increased expression of WNT4 mRNA CTD PMID:16780995 tetrachloromethane increases expression ISO RGD:733868 6480464 Carbon Tetrachloride results in increased expression of WNT4 mRNA, Carbon Tetrachloride results in increased expression of WNT4 protein CTD PMID:33640489 , PMID:35411647 tetrachloromethane multiple interactions ISO RGD:733868 6480464 Carbon Tetrachloride promotes the reaction [Nicotine results in increased expression of WNT4 mRNA] more ... CTD PMID:33640489 , PMID:35411647 trametinib multiple interactions EXP 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of WNT4 mRNA CTD PMID:36139627 trichostatin A increases expression EXP 6480464 trichostatin A results in increased expression of WNT4 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions EXP 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT4 mRNA CTD PMID:27188386 triptonide decreases expression ISO RGD:733868 6480464 triptonide results in decreased expression of WNT4 mRNA CTD PMID:33045310 valproic acid increases methylation EXP 6480464 Valproic Acid results in increased methylation of WNT4 gene CTD PMID:29154799 valproic acid affects expression ISO RGD:733868 6480464 Valproic Acid affects the expression of WNT4 mRNA CTD PMID:17963808 valproic acid decreases expression ISO RGD:621348 6480464 Valproic Acid results in decreased expression of WNT4 mRNA CTD PMID:23665938 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of WNT4 mRNA CTD PMID:25979313 valproic acid multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT4 mRNA CTD PMID:27188386 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of WNT4 mRNA CTD PMID:23179753 more ... vorinostat increases expression EXP 6480464 vorinostat results in increased expression of WNT4 mRNA CTD PMID:26272509 vorinostat multiple interactions EXP 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT4 mRNA CTD PMID:27188386
